Similar articles

• [Lamivudine treatment consensus from relative experts].

  Lamivudine Clinical Practice Group. Lamivudine Clinical Practice Group. Zhonghua Gan Zang Bing Za Zhi. 2002 Apr;10(2):157-8. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12108391 Chinese. No abstract available.
• Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.

  Li D, Xu DZ, Choi BC, Men K, Zhang JX, Lei XY, Yan YP. Li D, et al. J Med Virol. 2005 Jun;76(2):203-7. doi: 10.1002/jmv.20353. J Med Virol. 2005. PMID: 15834875
• [Effect of high viral hepatitis B virus DNA loads on vertical transmission of hepatitis B virus in late-pregnant women].

  Yang S, Liu M, Wang L. Yang S, et al. Zhonghua Fu Chan Ke Za Zhi. 2008 May;43(5):329-31. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 18953863 Clinical Trial. Chinese.
• Hepatitis B virus infection--natural history and clinical consequences.

  Ganem D, Prince AM. Ganem D, et al. N Engl J Med. 2004 Mar 11;350(11):1118-29. doi: 10.1056/NEJMra031087. N Engl J Med. 2004. PMID: 15014185 Review. No abstract available.
• Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.

  Morrey JD, Korba BE, Sidwell RW. Morrey JD, et al. Antivir Ther. 1998;3(Suppl 3):59-68. Antivir Ther. 1998. PMID: 10726056 Review.